Xu Xinping, Yin Yue, Li Dayan, Yao Binwei, Zhao Li, Wang Haoyu, Wang Hui, Dong Ji, Zhang Jing, Peng Ruiyun
Beijing Institute of Radiation Medicine, Beijing, China.
Front Pharmacol. 2022 Jul 22;13:930831. doi: 10.3389/fphar.2022.930831. eCollection 2022.
Clinically, drug-induced torsades de pointes (TdP) are rare events, whereas the reduction of the human ether-à-go-go-related gene (hERG) current is common. In this study, we aimed to explore the specific factors that contribute to the deterioration of hERG inhibition into malignant ventricular arrhythmias. Cisapride, a drug removed from the market because it caused long QT (LQT) syndrome and torsade de pointes (TdP), was used to induce hERG inhibition. The effects of cisapride on the hERG current were evaluated using a whole-cell patch clamp. Based on the dose-response curve of cisapride, models of its effects at different doses (10, 100, and 1,000 nM) on guinea pig heart were established. The effects of cisapride on electrocardiogram (ECG) signals and QT interval changes in the guinea pigs were then comprehensively evaluated by multi-channel electrical mapping and high-resolution fluorescence mapping, and changes in the action potential were simultaneously detected. Cisapride dose-dependently inhibited the hERG current with a half inhibitory concentration (IC50) of 32.63 ± 3.71 nM. The complete hERG suppression by a high dose of cisapride (1,000 nM) prolonged the action potential duration (APD), but not early after depolarizations (EADs) and TdP occurred. With 1 μM cisapride and lower Mg/K, the APD exhibited triangulation, dispersion, and instability. VT was induced in two of 12 guinea pig hearts. Furthermore, the combined administration of isoproterenol was not therapeutic and increased susceptibility to ventricular fibrillation (VF) development. hERG inhibition alone led to QT and ERP prolongation and exerted an anti-arrhythmic effect. However, after the combination with low concentrations of magnesium and potassium, the prolonged action potential became unstable, triangular, and dispersed, and VT was easy to induce. The combination of catecholamines shortened the APD, but triangulation and dispersion still existed. At this time, VF was easily induced and sustained.
临床上,药物诱发的尖端扭转型室性心动过速(TdP)是罕见事件,而人类ether-à-go-go相关基因(hERG)电流降低则较为常见。在本研究中,我们旨在探究导致hERG抑制恶化为恶性室性心律失常的具体因素。西沙必利是一种因导致长QT(LQT)综合征和尖端扭转型室性心动过速(TdP)而退市的药物,被用于诱导hERG抑制。采用全细胞膜片钳技术评估西沙必利对hERG电流的影响。根据西沙必利的剂量反应曲线,建立其在不同剂量(10、100和1000 nM)对豚鼠心脏作用的模型。然后通过多通道电标测和高分辨率荧光标测全面评估西沙必利对豚鼠心电图(ECG)信号和QT间期变化的影响,并同时检测动作电位的变化。西沙必利剂量依赖性抑制hERG电流,半数抑制浓度(IC50)为32.63±3.71 nM。高剂量西沙必利(1000 nM)完全抑制hERG可延长动作电位时程(APD),但未出现早期后除极(EADs)且未发生TdP。使用1 μM西沙必利且降低镁/钾浓度时,APD出现三角化、离散和不稳定。12只豚鼠心脏中有2只诱发了室性心动过速(VT)。此外,联合使用异丙肾上腺素并无治疗作用,且增加了发生心室颤动(VF)的易感性。单独的hERG抑制导致QT和有效不应期(ERP)延长,并发挥抗心律失常作用。然而,与低浓度镁和钾联合后,延长的动作电位变得不稳定、呈三角形且离散,且易于诱发VT。儿茶酚胺联合使用缩短了APD,但三角化和离散仍然存在。此时,VF易于诱发且持续存在。